San Diego, California-- (Newsfile Corp. - April 3, 2025) - Sonim Technologies, Inc. (NASDAQ: SONM) today confirmed that it has received an unsolicited non-binding proposal from Orbic North America, ...
IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...
Meatopia takes place at SWG3 Glasgow in June and international barbecue experts have been added to the lineup.